Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Import Safety Legislation: Generic Firms Could Accept Fees, Not Delays

Executive Summary

FDA's decision to invoke its Application Integrity Policy with Ranbaxy emphasizes the political risks that the generic industry faces as the debate on import safety returns the fore in Congress

You may also be interested in...



ANDA User Fees: Industry Takes Holistic Approach, Wants Whole New Office

The generics industry is pushing FDA to create a commissioner-level office dedicated to handling issues related to ANDAs during negotiations over the creation a user fee program for generic drugs

ANDA User Fees: Industry Takes Holistic Approach, Wants Whole New Office

The generics industry is pushing FDA to create a commissioner-level office dedicated to handling issues related to ANDAs during negotiations over the creation a user fee program for generic drugs

Generics Industry Faces Five Major Challenges, Actavis CEO Says (We're Partly Responsible For One Of Them, He Acknowledges)

U.S. ANDA makers are ending their silver anniversary year on a glum note

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS050753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel